Welcome to LookChem.com Sign In|Join Free
  • or
2,3-Di(furan-2-yl)-6-phenylquinoxaline is a difuran-substituted quinoxaline derivative identified as a potent inhibitor of the PI3Kα H1047R mutant, a key oncogenic target in cancer. It exhibits significant inhibitory activity (EC50 = 0.137 μM) and demonstrates anti-cancer effects by reducing p-AKT phosphorylation, arresting the cell cycle at the G1 phase, and inducing apoptosis through caspase activation. 2,3-di(furan-2-yl)-6-phenylquinoxaline represents a promising lead for developing novel PI3Kα inhibitors.

1095200-47-7

Post Buying Request

1095200-47-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1095200-47-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1095200-47-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,9,5,2,0 and 0 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1095200-47:
(9*1)+(8*0)+(7*9)+(6*5)+(5*2)+(4*0)+(3*0)+(2*4)+(1*7)=127
127 % 10 = 7
So 1095200-47-7 is a valid CAS Registry Number.

1095200-47-7Downstream Products

1095200-47-7Relevant academic research and scientific papers

One-step approach for the synthesis of functionalized quinoxalines mediated by T3P-DMSO or T3P: Via a tandem oxidation-condensation or condensation reaction

Harsha, Kachigere B.,Rangappa, Kanchugarkoppal S.

, p. 57154 - 57162 (2016)

An easy and efficient propylphosphonic anhydride (T3P)-DMSO or T3P mediated oxidation-condensation or condensation reaction for the synthesis of quinoxalines derived from the interaction of different arrays of condensing partners with ortho-phenylene diamines (o-PDs) under simple and mild reaction conditions in one step has been reported for the first time.

Difuran-substituted quinoxalines as a novel class of PI3Kα H1047R mutant inhibitors: Synthesis, biological evaluation and structure-activity relationship

Zhang, Ning,Yu, Zhimei,Yang, Xiaohong,Zhou, Yan,Tang, Qing,Hu, Ping,Wang, Jia,Zhang, Shao-Lin,Wang, Ming-Wei,He, Yun

, p. 37 - 49 (2018)

Phosphatidylinositol 3-kinase α (PI3Kα) is the most frequently mutated kinase in human cancers, making it an attractive therapeutic target for cancer treatment. We identified a structurally novel PI3Kα H1047R mutant inhibitor Hit-01 (EC50 = 76.0 μM) through a high-throughput screening campaign. Chemical optimizations enabled us to discover compound 7b, which strongly inhibited PI3Kα H1047R mutant with an EC50 value of 0.137 μM, over 500-fold more potent than Hit-01. Western blotting analysis suggested that 7b could decrease the phosphorylation level of p-AKT, another proof that 7b inhibited PI3Kα H1047R function. Cell viability assay revealed that 7b inhibited HCT116 cancer cell growth with an IC50 value of 11.23 μM. In addition, 7b was found to arrest cell cycle at G1 phase and induce cell apoptosis via up-regulation of caspase-3, caspase-8 and caspase-9 protein expressions. Collectively, all these data demonstrated that 7b could be a promising lead for the development of structurally novel PI3Kα inhibitors.

Gallium(III) triflate-catalyzed synthesis of quinoxaline derivatives

Cai, Jing-Jing,Zou, Jian-Ping,Pan, Xiang-Qiang,Zhang, Wei

supporting information; scheme or table, p. 7386 - 7390 (2009/05/07)

Gallium(III) triflate-catalyzed reactions of phenylene-1,2-diamines and 1,2-diketones produce quinoxalines in excellent to quantitative yields. The reactions proceed with 1 mol % catalyst in ethanol at room temperature. The catalyst can be recycled for at

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1095200-47-7